Literature DB >> 22281605

Cancers with increasing incidence trends in the United States: 1999 through 2008.

Edgar P Simard1, Elizabeth M Ward, Rebecca Siegel, Ahmedin Jemal.   

Abstract

Despite declines in incidence rates for the most common cancers, the incidence of several cancers has increased in the past decade, including cancers of the pancreas, liver, thyroid, and kidney and melanoma of the skin, as well as esophageal adenocarcinoma and certain subsites of oropharyngeal cancer associated with human papillomavirus (HPV) infection. Population-based incidence data compiled by the North American Association of Central Cancer Registries were used to examine trends in incidence rates from 1999 through 2008 for the 7 cancers listed by sex, age group, race/ethnicity, and stage at diagnosis. Joinpoint regression was used to calculate average annual percent changes in incidence rates (1999-2008). Rates for HPV-related oropharyngeal cancer, esophageal adenocarcinoma, cancer of the pancreas, and melanoma of the skin increased only in whites, except for esophageal adenocarcinoma, which also increased in Hispanic men. Liver cancer rates increased in white, black, and Hispanic men and in black women only. In contrast, incidence rates for thyroid and kidney cancers increased in all racial/ethnic groups, except American Indian/Alaska Native men. Increases in incidence rates by age were steepest for liver and HPV-related oropharyngeal cancers among those aged 55 [corrected] to 64 years and for melanoma of the skin in those aged 65 years and older. Notably, for HPV-related oropharyngeal cancer in men and thyroid cancer in women, incidence rates were higher in those aged 55 to 64 years than in those aged 65 years and older. Rates increased for both local and advanced stage diseases for most cancer sites. The reasons for these increasing trends are not entirely known. Part of the increase (for esophageal adenocarcinoma and cancers of the pancreas, liver, and kidney) may be linked to the increasing prevalence of obesity as well as increases in early detection practices for some cancers. These rising trends will exacerbate the growing cancer burden associated with population expansion and aging. Additional research is needed to determine the underlying reasons for these increasing trends.
Copyright © 2012 American Cancer Society, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22281605     DOI: 10.3322/caac.20141

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  261 in total

Review 1.  Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma.

Authors:  Igor P Pogribny; Ivan Rusyn
Journal:  Cancer Lett       Date:  2012-02-02       Impact factor: 8.679

2.  Ten years of progress in head and neck cancers.

Authors:  Shrujal Baxi; Matthew Fury; Ian Ganly; Shyam Rao; David G Pfister
Journal:  J Natl Compr Canc Netw       Date:  2012-07-01       Impact factor: 11.908

3.  Evaluation of the role of downregulation of SNF5/INI1 core subunit of SWI/SNF complex in clear cell renal cell carcinoma development.

Authors:  Elzbieta Sarnowska; Michal Szymanski; Nataliia Rusetska; Marcin Ligaj; Iga Jancewicz; Pawel Cwiek; Marta Skrodzka; Marcin Leszczynski; Joanna Szarkowska; Alicja Chrzan; Malgorzata Stachowiak; Jaroslaw Steciuk; Anna Maassen; Lech Galek; Tomasz Demkow; Janusz A Siedlecki; Tomasz J Sarnowski
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

4.  Antiangiogenic antibody improves melanoma detection by fluorescently labeled therapeutic antibodies.

Authors:  Larissa Sweeny; Andrew Prince; Neel Patel; Lindsay S Moore; Eben L Rosenthal; Brian B Hughley; Jason M Warram
Journal:  Laryngoscope       Date:  2016-08-31       Impact factor: 3.325

5.  Reduced feeding tube duration with intensity-modulated radiation therapy for head and neck cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis.

Authors:  Beth M Beadle; Kai-Ping Liao; Sharon H Giordano; Adam S Garden; Katherine A Hutcheson; Stephen Y Lai; B Ashleigh Guadagnolo
Journal:  Cancer       Date:  2016-09-23       Impact factor: 6.860

6.  Evolution of standardized clinical pathways: refining multidisciplinary care and process to improve outcomes of the surgical treatment of esophageal cancer.

Authors:  Sheraz R Markar; Henner Schmidt; Sonia Kunz; Artur Bodnar; Michal Hubka; Donald E Low
Journal:  J Gastrointest Surg       Date:  2014-04-29       Impact factor: 3.452

7.  Utilization of renal mass biopsy in patients with renal cell carcinoma.

Authors:  John T Leppert; Janet Hanley; Todd H Wagner; Benjamin I Chung; Sandy Srinivas; Glenn M Chertow; James D Brooks; Christopher S Saigal
Journal:  Urology       Date:  2014-02-12       Impact factor: 2.649

8.  Human papillomavirus-related carcinomas of the sinonasal tract.

Authors:  Justin A Bishop; Theresa W Guo; David F Smith; Hao Wang; Takenori Ogawa; Sara I Pai; William H Westra
Journal:  Am J Surg Pathol       Date:  2013-02       Impact factor: 6.394

9.  Improving the efficacy of appearance-based sun exposure interventions with the terror management health model.

Authors:  Kasey Lynn Morris; Douglas P Cooper; Jamie L Goldenberg; Jamie Arndt; Frederick X Gibbons
Journal:  Psychol Health       Date:  2014-06-06

10.  A potential role for immunotherapy in thyroid cancer by enhancing NY-ESO-1 cancer antigen expression.

Authors:  Viswanath Gunda; Dennie T Frederick; Maria J Bernasconi; Jennifer A Wargo; Sareh Parangi
Journal:  Thyroid       Date:  2014-06-30       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.